Agilent Technologies Denmark ApS recalled 65 units of its FLEX Monoclonal Mouse Anti-Human CD20cy, Clone L26 on August 11, 2025. The recall stems from potential weak staining that could lead to false negative CD20 identification. Healthcare providers and patients should stop using the product immediately.
Their is the potential for weak staining which may result in false negative CD20 identification.
Patients and healthcare providers should stop using this device immediately. Follow the recall instructions provided by the manufacturer. Contact Agilent Technologies Denmark ApS or your healthcare provider for instructions. Notification method: N/A
The recalled product is FLEX Monoclonal Mouse Anti-Human CD20cy, Clone L26, with catalog number GA60461-2CN. It was distributed nationwide in the U.S. The lot numbers affected include 41781549, 41762487, and 41651581.
The product may show weak staining, potentially resulting in false negative identification of CD20. This could impact the classification of B-cell neoplasms.
As of the report date, no specific incidents or injuries have been documented related to the recall. The potential for inaccuracies in test results poses a significant risk.
Stop using the product immediately. Follow the recall instructions provided by Agilent Technologies. Contact your healthcare provider for further guidance.
For more information, reach Agilent Technologies Denmark ApS. Visit their website or call their support line for assistance.
Glenmark Pharmaceuticals Inc. recalled 13,824 tubes of Azelaic Acid Gel on September 17, 2025. The recall stems from market complaints regarding a gritty texture. Consumers should stop using the product immediately and contact their healthcare provider.
Skin MD by Dr Monika Kiripolsky recalled its Body Acne Cleanser on September 12, 2025. The recall follows the discovery of elevated benzene levels in the product. This contamination poses a high health risk to consumers in California and Georgia.
Private Label Skin Care recalled its Micronized BPO Gel Cleanser 10% on September 12, 2025. Elevated benzene levels prompted the recall in California and Georgia. Consumers must stop using the product immediately and seek guidance from healthcare providers.